Abcentra LLC, a clinical-stage biopharmaceutical company, has named Timothy Wright, MD as its new director, it was reported on Wednesday.
Wright is the general partner at Time Bioventures and is a rheumatologist and drug developer. He has served in various senior leadership roles in research and development at Pfizer, Novartis, California Institute for Biomedical Research (Calibr/Scripps Research), and Regulus Therapeutics. He has served as chief of Rheumatology at the University of Pittsburgh.
Wright completed his MD, post-doctoral clinical, and research training at Johns Hopkins.
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
WuXi Biologics honoured for water security by CDP
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services